Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Evaluation of Hypofractionated Stereotactic RT (SBRT) Using CyberKnife for Patients With Low and Intermediate Risk of Progression Prostate Cancer.

NCT03225235 is registered in ClinicalTrials.gov with The Greater Poland Cancer Centre as lead sponsor.

NCT NCT03225235
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03225235 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Evaluation of Hypofractionated Stereotactic RT (SBRT) Using CyberKnife for Patients With Low and Intermediate Risk of Progression Prostate Cancer.
Lead sponsor
The Greater Poland Cancer Centre
Phase
Not applicable
Overall status
Unknown status
Start date
August 26, 2013
Completion date
August 31, 2025
Enrollment
600 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer